If you would like more information about the profile please click
. You will be directed to a new page where you will need
to provide some information about yourself/your business cooperation needs and submit
your expression of interest in the profile . A Network Partner will then contact
you to discuss your interest in greater detail.
A French Technology Transfer Office is acting on behalf of an established public laboratory of the Paris region which has developed a collagen-based hydrogel.This patented hydrogel has been proven to accelerate wound healing when used as a drug vector. The French research centre is looking for biotech or medtech companies in order to develop specific wound dressing applications such as anti-inflammation, pain relief, antibiotic effect via a license agreement or a technical cooperation agreement.
The French TTO (Technology Transfer Office) is acting on behalf of an established public laboratory of the leading French scientific and medical university based in the Paris region.
The innovation is a composite dressing made of dense collagen hydrogel able to release progressively drugs for the healing of chronic wounds.
*Market Challenges :
Chronic wounds such as venous leg ulcers, bed sores or diabetic foot ulcers represent a major health issue. It is necessary to follow-up to ensure the optimal treatment of these wounds. It usually consists in a debridement followed by a compressive method. When this technique is not effective enough, the application of wound dressings is required.
The major drawbacks of this technique are :
-the frequent changes of dressings
-the numerous types of materials required (according to the stage of healing)
-The costs of hospital/nurse
The population is aging in western countries and diabetes is becoming epidemic. The prevalence of chronic wounds will arise and an efficient and cost-effective solution are then needed to promote skin wound healing.
* Areas of application :
-Wound healing in leg ulcers
-Wound healing in bed sores
-Wound healing in diabetic foot ulcers
the TTO is looking for a co-development partner to bring additional proof of concept with more drugs (anti-inflammatory, pain relievers, antibiotic) and validation in animal studies via a license agreement or technical cooperation agreement.
*key words :
Compared to the the classic treatment with wound dressings, the hydrogel brings confort by re-hydrating itself in contact with the wound exudates, providing an adequate moist environment. Therefore it can be kept several days in a row while releasing drug. In addition it prevents painful removal of the dressing.
Prototype : an experimental demonstrator has been designed.
Patent : recording in process.
Technical cooperation agreement : the potential industrial partner should be interested to invest in co-development of specific wound healing applications, by means of its manufacturing capacities or drug store resources.
License agreement : after validating specific wound dressing applications, the potential industrial partner should be interested in negociating a license agreement in order to commercialize an innovative wound dressing using the patented collagen-based hydrogel.